.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Baxter
McKinsey
Queensland Health
Novartis
Cantor Fitzgerald
Moodys
Dow
Argus Health
UBS

Generated: November 24, 2017

DrugPatentWatch Database Preview

VERDESO Drug Profile

« Back to Dashboard

What is the patent landscape for Verdeso, and what generic Verdeso alternatives are available?

Verdeso is a drug marketed by Aqua Pharms and is included in one NDA. There are five patents protecting this drug.

This drug has forty-eight patent family members in twenty countries and one supplementary protection certificate in one country.

The generic ingredient in VERDESO is desonide. There are twenty-nine drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the desonide profile page.

Pharmacology for VERDESO

Medical Subject Heading (MeSH) Categories for VERDESO

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aqua Pharms
VERDESO
desonide
AEROSOL, FOAM;TOPICAL021978-001Sep 19, 2006RXYesYes► Subscribe► SubscribeY ► Subscribe
Aqua Pharms
VERDESO
desonide
AEROSOL, FOAM;TOPICAL021978-001Sep 19, 2006RXYesYes► Subscribe► SubscribeY ► Subscribe
Aqua Pharms
VERDESO
desonide
AEROSOL, FOAM;TOPICAL021978-001Sep 19, 2006RXYesYes► Subscribe► SubscribeY ► Subscribe
Aqua Pharms
VERDESO
desonide
AEROSOL, FOAM;TOPICAL021978-001Sep 19, 2006RXYesYes► Subscribe► SubscribeY ► Subscribe
Aqua Pharms
VERDESO
desonide
AEROSOL, FOAM;TOPICAL021978-001Sep 19, 2006RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Tradename: VERDESO

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,263,580Vitamin formulation► Subscribe
8,449,867Microemulsion and sub-micron emulsion process and compositions► Subscribe
8,629,128Vitamin formulation► Subscribe
8,298,515Vitamin formulation► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: VERDESO

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2006024095► Subscribe
Germany69937802► Subscribe
European Patent Office1796636► Subscribe
Canada2578594► Subscribe
Canada2333869► Subscribe
Australia6069299► Subscribe
South Africa200702702► Subscribe
Canada2756674► Subscribe
South Korea20070069155► Subscribe
Japan2002524490► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: VERDESO

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB02/033United Kingdom► SubscribePRODUCT NAME: FORMOTEROL (OPTIONALLY IN THE FORM OF THE FREE BASE OR A PHYSIOLOGICALLY ACCEPTABLE SALT THEREOF, OR A SOLVATE OF SUCH FREE BASE OR SALT ESPECIALLY AS FORMOTEROL FUMARATE DIHYDRATE) AND BUDESONIDE; REGISTERED: SE SE16047, 16048 20000825; UK PL17901/0091 20010515; UK PL17901/0092 20010515
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Chubb
QuintilesIMS
Express Scripts
Federal Trade Commission
US Department of Justice
UBS
Merck
Fuji
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot